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Protein productionEscherichia coli is by far the most widely used bacterial host for the production of membrane proteins. Usually,
different strains, culture conditions and production regimes are screened for to design the optimal production
process. However, these E. coli-based screening approaches often do not result in satisfactorymembrane protein
production yields. Recently, it has been shown that (i) E. coli strains with strongly improved membrane protein
production characteristics can be engineered or selected for, (ii) many membrane proteins can be efﬁciently
produced in E. coli-based cell-free systems, (iii) bacteria other than E. coli can be used for the efﬁcient production
of membrane proteins, and, (iv) membrane protein variants that retain functionality but are produced at higher
yields than the wild-type protein can be engineered or selected for. This article is part of a Special Issue entitled:
Protein trafﬁcking and secretion in bacteria. Guest Editors: Anastassios Economou and Ross Dalbey.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
In both pro- and eukaryotes 20–30% of all genes encode membrane
proteins, which usually form supra-molecular complexes acting in
many different and often essential capacities and are fundamental
in maintaining the function of a healthy cell/organism [1]. Membrane
proteins also play key roles in many diseases and around 70% of all
drugs act on membrane proteins [2] (http://www.drugs.com/top200.
html). The natural abundance of membrane proteins is often too low
to isolate sufﬁcientmaterial for in vitro functional and structural studies.
Furthermore, the use of natural sources excludes the possibility of
genetically modifying proteins to facilitate their detection and/or
puriﬁcation, and efﬁciently labeling them for nuclearmagnetic resonance
(NMR) and crystallographic studies.
There are two classes of membrane proteins: β-barrel and helical
bundle membrane proteins [3]. Usually, β-barrel membrane proteins
can be produced in E. coli as inclusion bodies fromwhich they are readily
isolated and refolded in their native conformation [4]. Nevertheless, to
determine the structure of a number of bacterial β-barrel membrane
proteins they were produced in the outer membrane rather than in in-
clusion bodies (e.g., [5,6]). There are only few examples of helical bundle
membrane proteins that could be isolated from inclusion bodies in their
native conformation (see e.g., [7]). Usually, the isolation of helicaltrafﬁcking and secretion in bac-
ey.
ights reserved.bundle membrane proteins from inclusion bodies is not successful.
Therefore, helical bundle membrane proteins must be produced in
such a way that they properly insert into the membrane from which
they can be puriﬁed after detergent extraction or wherein they can be
studied directly. This makes that in general the production of helical
bundle membrane proteins is more complex than the production of
β-barrel membrane proteins. In this review, we will deal only with the
production of helical bundle membrane proteins, hereafter referred to
as membrane proteins.
E. coli is the most widely used bacterial host when attempting to
producemembrane proteins. Usually, a variety of strains, culture condi-
tions and production regimes are screened for to design the optimal
membrane protein production process (e.g., [8,9]). However, yields –
especially of eukaryotic membrane proteins – are usually not sufﬁcient
for functional and structural studies. Therefore, eukaryotic protein pro-
duction hosts are increasingly used for the production of eukaryotic
membrane proteins [10,11]. However, the high costs involved in using
eukaryotic hosts for producing eukaryotic membrane proteins make
that there is a growing interest in developing cost-effective bacterial-
based production alternatives for these proteins.
Recently, considerable progress has been made in producing both
pro- and eukaryotic membrane proteins using bacterial-based systems.
It has been reported that (i) E. coli strains with strongly improved mem-
brane protein production characteristics can be engineered or selected
for, (ii) many membrane proteins can be efﬁciently produced in E. coli-
based cell-free systems, (iii) bacteria other than E. coli can be used for
the efﬁcient production of membrane proteins, and (iv) membrane pro-
tein variants that retain functionality but are produced at higher yields
than the wild-type protein can be engineered or selected for. The aim
of this review is to give a comprehensive overview of these exciting
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and newly developed analytical methods for monitoring membrane
protein production has been key tomanyof these developments. There-
fore, we will start with a brief introduction to these two topics.2. Membrane protein biogenesis
Membrane protein production and biogenesis are intimately linked
as membrane proteins must be produced in such a way that they insert
into themembrane and fold properly. The biogenesis ofmembrane pro-
teins in the cytoplasmic or innermembrane of thewidely used bacterial
membrane production host E. coli has been extensively studied (see [12]
and references herein). Below, an overview is presented of what is
known about the biogenesis of membrane proteins in the inner mem-
brane of E. coli (this overview is supported by Fig. 1).
In E. coli, ribosome-inner membrane protein nascent chain com-
plexes (RNCs) are targeted cotranslationally to the membrane via the
SRP pathway (comprising the signal recognition particle (SRP) and its
receptor FtsY) [13,14]. At the membrane, the RNC docks at the Sec-
translocon — a protein-conducting channel that facilitates both the
translocation of hydrophilic polypeptide chains across the membrane
and the insertion of transmembrane segments into the lipid bilayer
[15,16]. The translocation of sizeable periplasmic loops requires the
ATPase SecA [17,18]. YidC has been proposed to mediate the transfer
of transmembrane segments from the Sec-translocon into the lipid
bilayer and can assist the folding of membrane proteins [19]. Some
membrane proteins are targeted via the SRP pathway or directly to YidC
[19]. YidD functions in the biogenesis of both YidC and Sec-YidC depen-
dent membrane proteins [20]. The SecDFYajC complex can play a role in
the biogenesis of membrane proteins [19]. Notably, it has been shown
that mRNAs encoding membrane proteins localize to the cytoplasmic
membrane in a translation-independent mechanism [21]. This may
indicate that mRNAs encoding membrane proteins are targeted to
the membrane.
Folding of soluble cytoplasmic domains ofmembraneproteinsmight
be supported by cytoplasmic chaperones such as DnaK, whereas that of
periplasmic domains of membrane proteins might be supported by
periplasmic chaperones such as DegP (which can also act as a protease).
The FtsH complex is involved in quality control and degradation of
membrane proteins [22,23].
Targeting and insertion of tail anchored (TA) proteins into the cyto-
plasmic membrane may occur in a post-translational manner via the
SRP/Sec-translocon system or an alternative pathway.Fig. 1.Membrane protein biogenesis in E. coli. Overview of the different components involved in
E. coli (see Section 2 for more information). Picture was taken from [9].Secretory proteins are targeted by the chaperone SecB in a mostly
posttranslational manner to the Sec-translocon [24]. The translocation
of secretory proteins is SecA dependent. The signal sequence of secretory
protein is removed by leaderpeptidase (Lep). The SecDFYajC complex can
also play a role in the translocation and folding of secreted proteins.
Recently, we have addressed in great detail how the heterologous
production of membrane proteins may be affected by differences in
themembrane protein biogenesismachinery of the differentmembrane
protein production platforms used (see [9] and references herein). Here,
we only brieﬂy mention the most important ones.
There are differences in polypeptide elongation and protein folding
rates between different prokaryotes and these rates are considerably
higher than the ones in eukaryotes. These different rates may cause
mistargeting and misfolding of heterologously produced membrane
proteins. Although there is a high homology between most of the key
components involved in membrane protein biogenesis in pro- and eu-
karyotic systems, there is some circumstantial evidence indicating that
this does not necessarily mean they are also well suited for assisting
the targeting, insertion and folding of heterologously produced mem-
brane proteins into the membrane [25–27]. Some membrane proteins
require membrane-protein-speciﬁc chaperones for proper folding,
(see e.g., [28]). Thus, it is possible that chaperones essential for the
heterologous production of membrane proteins may be absent in
the production host used.
Other organismal factors are lipid composition and glycosylation.
Differences in lipid composition between membrane systems can have
a signiﬁcant effect on the insertion, folding and functioning of a heterolo-
gously producedmembrane proteins [29,30]. Glycosylation of eukaryotic
membrane proteins can be essential for proper folding, stability and also
function [31]. The most commonly used prokaryotic membrane protein
production vehicles, E. coli and the Gram-positive bacterium Lactococcus
lactis (see Section 5.1.), cannot glycosylate proteins.
Finally, it is of note that the high-level production of membrane pro-
teins, including homologous ones, may saturate the membrane protein
biogenesis machinery of the production host. Indeed, for E. coli it has
been shown that the production of both homologous and heterologous
membrane proteins can lead to the saturation of the Sec-translocon
capacity, which negatively affects the ﬁtness of the E. coli cell as well
as membrane protein production yields [26,32,33].
3. Monitoring membrane protein production
Monitoring the localization, quantity and quality of produced mem-
brane proteins is important to allow assessment and optimization ofmembrane protein biogenesis andmembrane protein biogenesis pathways operational in
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proteins end up in the lipid bilayer or in inclusion bodies. Therefore,
the ﬁrst step in monitoring membrane protein production is usually
the fractionation of the production host into an insoluble fraction
(inclusion bodies), a soluble fraction and a membrane fraction [34].
From here on if not stated otherwise we mean with membrane the
bacterial cytoplasmic membrane.
Coomassie/silver stained SDS-polyacrylamide gels have been
routinely used to detect produced membrane proteins in (sub-frac-
tionated) production hosts. They allow assessing the integrity and
the quantity of produced membrane proteins. Immuno-blotting, using
antibodies against e.g., a production or puriﬁcation tag, is also widely
used to detect proteins. Due to the hydrophobic nature of membrane
proteins their transfer from a gel to blotting membrane can be trouble-
some, making immuno-blotting less suitable for quantitative purposes.
Size exclusion chromatography (SEC), often combined with static light
scattering, is usually used to assess the quality of puriﬁedmembrane pro-
tein material (see e.g., [35,36]). These ‘classical’ approaches to monitor
membrane protein production are very laborious, time-consuming and
the gel-based approaches often not very accurate. Therefore alternative
methods have been developed.
To easily and rapidly monitor the production of large numbers of
soluble proteins in E. coli at low costs, the so-called colony ﬁltration
(CoFi) blotting method was developed [37]. In this method colonies
are transferred from an agar plate to a ﬁlter membrane where protein
production is induced and cells subsequently lysed. Upon cell lysis, the
soluble proteins diffuse through the ﬁlter membrane and are captured
on a nitrocellulose membrane, whereas inclusion bodies cannot pass
through the ﬁlter. Subsequently, the nitrocellulose membrane is incu-
bated with antibodies or probes that speciﬁcally recognize the protein
of interest. The CoFi blotting method was modiﬁed so that it can also
be used to monitor the production of detergent solubilized membrane
proteins [38].
C-terminal selectable markers that confer a drug resistance pheno-
type have been used to assess membrane protein production yields in
E. coli and theGram-positive bacterium L. lactis [39–41]. The idea behind
using these selectable markers is very simple, the higher the yields of
a fusion produced in the membrane the higher amounts of drugs
cells can cope with. Notably, just like the CoFi blotting method also
the use of selectable markers that confer a drug resistance to assess
membrane protein production yields does not require any special
infrastructure.
Fusing Green Fluorescent Protein (GFP) to the C-terminus of amem-
brane protein enables monitoring the levels of membrane-integrated
material in whole cells [42–45]. The GFP-moiety does not fold properly
(and is therefore non-ﬂuorescent) if the membrane protein GFP-fusion
ends up in inclusion bodies, but it becomes ﬂuorescent if themembrane
protein is inserted into the membrane. Correctly folded GFP is not
denatured in SDS-polyacrylamide gel solubilization (SB) buffer at tem-
peratures below 37 °C. Usingwhole cells as startingmaterial, themem-
brane protein GFP-fusion can thus be visualized directly through in-gel
ﬂuorescence in SDS-polyacrylamide gels [43]. This enables to rapidly
assess the integrity of the produced material quantitatively, and is a
welcome alternative for immuno-blotting. Since the GFP moiety of a
membrane protein–GFP fusion that has been inserted in themembrane
remains properly folded in SB buffer it will migrate faster in a gel than a
non-inserted fusion whose GFP moiety is denatured in SB buffer. This
allows using a simple SDS-polyacrylamide gel/immuno-blotting based
assay to get an idea about the fraction of the total produced protein
that is integrated in the membrane [46,47].
Membrane protein GFP-fusions allow using minute amounts of
detergent solubilized whole cells/membranes to rapidly evaluate
both their production levels and degree of monodispersity using
ﬂuorescence-detection size-exclusion chromatography (FSEC) [48].
Using different ﬂuorescent fusion partners membrane multiprotein
complexes have been characterized usingmulticolour FSEC [49]. Ratherthan fusing ﬂuorescent proteins to membrane proteins a ﬂuorescent
multivalent NTA probe that interacts with polyhistidine-tags on target
proteins can be used for FSEC [50].
The thiol-speciﬁc ﬂuorochrome N-[4-(7-diethylamino-4-methyl-3-
coumarinyl)phenyl]maleimide (CPM) is used for stability proﬁling of
puriﬁed membrane proteins [51]. The CPM-based stability assay uses
the chemical reactivity of the frequently in transmembrane segments
occurring native cysteines as an indicator for the overall integrity of
the folded state. FSEC and the CPM-based stability assay have been
combined to rapidly assess the suitability of membrane proteins for
crystallography [52].
Fusion partners are routinely attached to the C-terminus rather than
N-terminus of a target membrane protein since attaching them to the
N-terminus may hamper targeting to the cytoplasmic membrane. The
location of the C-terminus (Cin/Cout) of the target membrane protein
determines in which compartment the fusion partner will end up. The
fusion partner should be active in the compartment it ends up in. Thus
far, only GFP variants that fold properly in the cytoplasm and not in
the periplasm have been used to make membrane protein GFP fusions.
For Cin membrane proteins this is not a problem. For Cout membrane
proteins gfp fusion expression vectors have been constructed that intro-
duce the genetic information encoding a transmembrane segment be-
tween the genetic information encoding the target membrane protein
and the genetic information encoding GFP [45]. This strategy can in
principle be applied to any fusion partner whose functionality is com-
partment dependent.
All the above described methods do not provide direct information
on the functionality of the produced proteins. To monitor the function-
ality of a membrane protein, its function should be known and also an
activity assay should be available. Depending on the protein e.g., binding
assays with ﬂuorescent or radioactive ligands or transport assays have
been used (for examples see [8]). Functional assays for membrane pro-
teins are usually carried out using isolatedmembranes or protein. How-
ever, sometimes also cells can be used. For instance, using ﬂuorescently
labeled ligands it has been shown that the levels of properly folded
GPCRs produced in E. coli can be monitored directly in cells with a
permeabilized outer membrane [53,54] (see also Section 6.2.).
4. Improving membrane protein production yields in E. coli-based
platforms
Why has E. coli become the most widely used bacterial host for
(membrane) protein production? The answer is largely for historical
reasons. The organism was isolated over a century ago and turned out
to be particularly easy to cultivate. Furthermore, a very large toolbox
of genetic, molecular biological and biochemical methods has been de-
veloped for E. coli. All this has paved the way for E. coli to become a fa-
vorite model organism and the most widely used bacterial platform
for the production of (membrane) proteins.
Obviously, during evolution there has not been selective pressure on
E. coli towards the production of (heterologous) membrane proteins.
However, this does not mean that it is impossible to engineer or select
for E. coli strains that can efﬁciently produce membrane proteins.
Indeed, there are now a number of examples of the creation of E. coli
strains with improved membrane protein production characteristics.
In addition, to avoid any toxic effects of membrane protein production
on the living E. coli cell and to facilitate the labeling of proteins for
NMR and crystallographic studies, E. coli-based cell-free protein produc-
tion systems can be used to produce membrane proteins.
4.1. Selecting and engineering E. coli strains with improved membrane pro-
tein production characteristics
4.1.1. Tuning transcription and translation rates
The E. coli strain BL21(DE3) and derivatives thereof are widely used
for protein production. The BL21(DE3) strain was originally developed
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the gene encoding the target is driven by the bacteriophage T7 RNA po-
lymerase (T7 RNAP), which transcribes much faster than E. coli RNAP
[56]. Expression of the gene encoding T7 RNAP is governed by the
lacUV5 promoter, which is a mutant that is more powerful than the
wild-type lac promoter [57]. The rationale behind BL21(DE3) is very
simple; themoremRNA synthesized, themore protein can be produced.
However, it has been shown that too high expression levels of
genes encoding membrane proteins can lead to the saturation of
the Sec-translocon capacity (see Section 2).
Almost two decades ago, in the laboratory of John Walker a simple
screening approach was used to isolate derivatives of BL21(DE3) with
improved membrane protein production characteristics [58]. E. coli
BL21(DE3) cells producing ‘toxic’ membrane proteins were plated on
solid medium with inducer to select for survivors, i.e., cells that
can cope with the toxic effects of membrane protein production.
The C41(DE3) and C43(DE3) strains – which have commonly be-
come known as the Walker strains – were isolated in this way and are
now widely used to produce membrane proteins. It should be noted
that the Walker strains do not show improved yields for all membrane
proteins tested [33,58]. It has been shown that mutations in the lacUV5
promoter governing expression of the gene encoding T7 RNAP are key
to the improved membrane protein production characteristics of the
Walker strains [33]. These mutations result in the production of much
lower amounts of T7 RNAP upon induction of expression than in
BL21(DE3). Subsequent lower production rates of the mRNA for the
target membrane protein ensure that the capacity of the Sec-translocon
is sufﬁcient to integrate the produced proteins in the membrane
[32,33,47].
Based on the characterization of theWalker strains, a derivative strain
of E. coli BL21(DE3), termed Lemo21(DE3), was engineered in which the
activity of the T7 RNAP can be precisely controlled by its natural inhibitor
T7 lysozyme (T7 Lys) [33]. In Lemo21(DE3) the gene encoding the T7 Lys
is on a plasmidunder control of a rhamnose promoter,which is extremely
well titratable and covers a broad range of expression intensities [59]. The
combination of the lacUV5- and the rhamnose promoters governing ex-
pression of the gene encoding T7 RNAP from the chromosome and the
gene encoding T7 Lys from a plasmid, respectively, guarantees thewidest
window of expression intensities possible. Therefore, in Lemo21(DE3)
the amount of membrane protein produced can be easily harmonized
with the Sec-translocon capacity of the cell [33,47]. The development of
this strain was sped up tremendously by using GFP-fusions to monitor
membrane protein production. Notably, the Lemo21(DE3) strain has
been used to producemembrane protein GFP-fusions fromwhich prop-
erly foldedmembrane proteinmaterial could be recovered for functional
and structural studies [47] (Fig. 2).
The above described ﬁndings indicate that tuning the transcription
rate is a powerful tool to improve membrane protein production yields.
In this respect it should bementioned that the rhamnose promoter used
to govern expression of the gene encoding T7 Lys in Lemo21(DE3) can
also be used directly to tune the expression intensity of genes encoding
membrane proteins, thereby improving membrane protein production
yields [59]. The importance of tuning the expression levels of genes
encoding membrane proteins for improving membrane proteinFig. 2. Optimizing membrane protein production yields in E. coli using Lemo21(DE3) and GFP-f
somally located gene encoding the T7 RNA polymerase (T7 RNAP) is governed by the notwell ti
sion of the gene encoding the natural inhibitor of the T7 RNA polymerase, T7 lysozyme (T7 L
plasmid. The pLemo plasmid has a p15A origin of replication and contains a chloramphenicol res
and its expression is governed by the T7lac promoter. The pET vector has a ColE1 origin of repli
marker are used. Membrane proteins are expressed as C-terminal GFP fusions. The GFP moiet
inserted in the cytoplasmicmembrane (see Section 3). B. Lemo21(DE3) cells are cultured in the
brane protein-GFP fusions is induced with 0.4 mM IPTG if no autoinduction based medium is u
fusions in the cytoplasmicmembrane. Subsequently, in-gel ﬂuorescence is used to assess the in
brane inserted to non-inserted membrane protein is monitored using an SDS-PAGE/immuno
detergent to optimally extract the produced membrane protein from the membrane, and to m
GFP-fusions can also be seen by eye. Finally, membrane proteins can be recovered from theGFP-
studies. Results observed for optimal production/solubilization conditions are marked (*).production yields is further supported by the isolation of a mutant
in a membrane protein expression vector based on the widely used
arabinose-inducible pBAD promoter system [60]. A single transversion
in a conserved region of the cyclic AMP receptor protein-binding site
reduces transcript levels more than twofold. This results in improved
cell growth and a twofold increase in membrane protein production
yields. Tuning translation rates by using expression vectors with ribo-
some binding sites of different strength can also be used to improve
membrane protein production yields [61]. Finally, expression vectors
encoding small N-terminal fusion tagswith different translation initiation
rates have also been used to improve membrane protein production
yields [62].
4.1.2. Drug resistance-based strain selection
A sophisticated selection strategy to isolate mutant strains of E. coli
with improved protein production characteristics for targeted mem-
brane proteins was recently described [39]. The gene encoding the
targeted membrane protein was simultaneously expressed from two
separate plasmids. Each plasmid was constructed such that upon ex-
pression the membrane protein was C-terminally fused to a different
cytoplasmic selection marker; i.e., a kanamycin resistance marker and
mouse dihydrofolate reductase, which confers resistance to trimetho-
prim. Cells containing both plasmids were exposed to treatments that
randomly introduce mutations and subsequently selected for growth
on selectivemedium. An increased resistance towards the two selection
drugs indicated an increased production of the target protein. Impor-
tantly, the use of a dual selection strategy considerably lowers the risk
of obtaining mutations that confer resistance to both drugs without
increasing membrane protein production levels. Furthermore, a rapid
method for curing isolated strains of the plasmids was used during the
selection process; the plasmids were removed by in vivo digestion
with the homing endonuclease I-CreI. It has been shown that in one of
the isolated strains the copy number of the expression plasmids is
considerably lower, suggesting that in this strain a lowered target gene
expression level improves membrane protein production yields (see
Section 4.1.1.). For the other strains it is not known why they have
improved membrane protein characteristics. Membrane proteins C-
terminally fused to the periplasmic drug resistance marker β-
lactamase have made it possible to use multi-copy based plasmid
libraries to select for strains with improved membrane protein
production characteristics by screening for increased ampicillin re-
sistance [40] (see Section 4.1.4.)
4.1.3. Co-production of biogenesis factors
Co-production of chaperones is routinely used to improve produc-
tion yields of soluble proteins (see e.g., [63]). Chen et al. pioneered this
approach for membrane proteins [64]. They tried to improve the pro-
duction yields of the magnesium transporter CorA in E. coli by co-
producing various components involved inmembrane protein biogene-
sis (SRP/FtsY, SecA), secretory protein targeting (SecA/B) and protein
folding in the cytoplasm (DnaK/J, GroEL/S; see the review by Genevaux
cum suis in this special issue for more information). CorA production
levels could be improved by the co-production of the cytoplasmic
DnaK/J chaperone system. The CorA transporter is a homopentamerusions.A. Schematic representation of the Lemo21(DE3) strain. Expression of the chromo-
tratable, isopropylβ-D-1-thiogalactopyranoside (IPTG) inducible lacUV5 promoter. Expres-
ys), is governed by the exceptionally well titratable rhamnose promoter from the pLemo
istancemarker. The gene encoding the targetmembrane protein is located on a pET vector
cation. For the production of membrane proteins pET vectors with a kanamycin resistance
y only folds properly and becomes ﬂuorescent when the membrane protein GFP fusion is
presence of different concentrations of rhamnose. The expression of genes encodingmem-
sed. Whole-cell ﬂuorescence is used to monitor the production of membrane protein-GFP
tegrity of the producedmembrane protein GFP-fusions. The ratio of the cytoplasmicmem-
-blotting based assay (see Section 3). C. The GFP-moiety facilitates the identiﬁcation of a
onitor the stability of a membrane protein in a detergent using FSEC. Membrane protein
fusion using a site-speciﬁc protease and subsequently be used for functional and structural
1743S. Schlegel et al. / Biochimica et Biophysica Acta 1843 (2014) 1739–1749and each protomer of CorA consists of a large N-terminal cytoplasmic
domain and two transmembrane segments at the C-terminus. The ar-
chitecture of CorA suggests that, unlike most other membrane proteins,
it is not targeted co-translationally via the SRP/Sec-translocon pathway,
but is targeted post-translationally [12]. Thus, it is likely that the DnaK/J
chaperone system is somehow involved in the targeting and folding of
CorA and could explain why co-production of this system improves
































































c1 c2 c3 c4 c5 c6In an effort to improve production yields of GPCRs in E. coli var-
ious components involved in membrane protein biogenesis (SRP,
FtsY, the Sec-translocon components SecY/E, YidC and FtsH), secre-
tory protein targeting/translocation (SecB, DnaK/DnaJ, Trigger Fac-
tor (TF) and the Sec-translocon components SecY/E) and protein
folding in the cytoplasm (GroEL/GroES, SecB, DnaK/DnaJ and TF)
were co-produced when producing different GPCRs (see [65] and
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sessment of the effect of the co-production of aforementioned
components on GPCR production levels using ﬂow cytometry. No-
tably, expression of the genes encoding the co-produced compo-
nents was induced well before the genes encoding the GPCRs
were induced. Only the co-production of the membrane-bound
quality control factor/protease FtsH greatly enhanced the production
yields of all four GPCRs. It has been proposed that the co-production
of FtsH ‘primes’ the cells for the toxic effects of producing the GPCRs
by inducing the expression of genes that may help the cell cope with
membrane protein production stress rather than it plays a more direct
role in the biogenesis of the GPCRs [66].
Finally, using a bitopic histidine kinase from E. coli and two archaeal
rhodopsins the effects of the co-production of the insertion and folding
factor YidC on membrane protein production yields were tested [67].
YidC co-production only had a positive effect on the production yields
of the two rhodopsins.
4.1.4. Identiﬁcation of factors improving production yields usingmulti-copy
based plasmid libraries
The effects of multi-copy based plasmid libraries of bacterial
chromosomal fragments on membrane protein production yields
were screened for using two separate systems that monitor: (i) elevated
ﬂuorescence conferred by enhanced production of GPCR–GFP fusions and
(ii) increased binding of ﬂuorescent ligand in cells producingmore active
receptor [68]. Three hits were isolated by both methods: nagD, encoding
the ribonucleotide phosphatase NagD; a fragment of nlpD, encoding a
truncation of the predicted lipoprotein NlpD, and the three-gene cluster
ptsN–yhbJ–npr, encoding three proteins of the nitrogen phosphotransfer-
ase system. Expression of these genes resulted in a 3- to 10-fold increase
in the production yields of different GPCRs. It has been proposed that the
expression of these genes may serve to maintain the integrity of the
bacterial periplasm and to provide a favorable environment for proper
membrane protein folding, possibly by inducing a ﬁne-tuned stress
response and/or viamodifying the composition of the bacterial cell enve-
lope. There is no experimental evidence supporting this. In another
screen using membrane proteins C-terminally fused to the drug resis-
tance marker β-lactamase, co-expression of ybaB, a gene encoding a
putative DNA-binding protein of unknown function, was found to en-
hance the production yields of a variety of GPCRs and other membrane
proteins in E. coli by up to 10-fold [40]. In the same study two more
genes, yciQ and glpQ, were identiﬁed, whose co-expression improved
membrane protein production yields. There is no ready explanation for
the positive effect of the co-expression of these genes onmembrane pro-
tein production yields.
4.1.5. Components hampering membrane protein production
It is also possible that there are host proteins that hamper membrane
protein production. Therefore, the production of the human GPCR CB1
fused to GFP was screened in an E. coli transposon library [69].
Fluorescence-activated cell sorting (FACS) was used to identify and
isolate cells with improved production yields for further characterization.
A transposon insertion in the dnaJ gene resulted in an increase in CB1-GFP
ﬂuorescence and an enhancement in production of membrane-
integrated CB1. Thus, the chaperone/co-chaperone DnaJ seems to
inhibit production of CB1. However, it was not shown if improved
yields also resulted in more functional material. DnaJ did not inhibit pro-
duction of another GPCR tested. This suggests that – at least in some cases
– the optimal strain background for the production of a membrane pro-
teinmay be protein-speciﬁc. Recently, it has been shown that membrane
protein production yields can also be improved in E. coli strains lacking
the tig gene, which encodes the cytoplasmic chaperone TF [67]. It has
been suggested that TF can competewith SRPbinding and therefore ham-
per the targeting of produced membrane proteins. Notably, combining
the tig deletion and the co-production of YidC (see Section 4.1.3.) canhave a positive additive effect on membrane protein production yields
[67].
In Section 4.1.3., the positive effects of the co-production of compo-
nents involved in membrane protein biogenesis were discussed. How-
ever, their co-production can also have a negative effect on membrane
protein production yields. It has been shown that co-production of
SRP can have a negative effect on membrane protein production yields
[67]. This was not expected in the light of the observations that mem-
brane protein production titrates out SRP, and that co-production of
SRP can improve the production of secretory heterologous proteins
equipped with an SRP-dependent signal sequence [70,71]. It has been
suggested that the different effects of the co-production of SRP on pro-
duction yields is somehow linked to the time these different proteins
occupy the Sec-translocon [67].
Taken together, different strategies have been used to create E. coli
strains with improved membrane protein production characteristics.
Unfortunately, the different strain backgrounds, expression plasmids,
membrane protein targets, culture and production regimes, and set-ups
to monitor membrane production yields used make it impossible to
compare all the studies described in this section. Anyways, it is
very likely that what we have seen so far is just the beginning of
the creation of E. coli strains with improved membrane protein pro-
duction characteristics.
4.2. Producing membrane proteins using E. coli based, cell-free systems
Cell-free protein production systems have been developed to
circumvent the toxic effects of protein production on the production
host and to label proteins for NMR and crystallographic studies [72].
Since cell-free systems are ‘open systems’, ongoing protein synthesis re-
actions can be easily manipulated, which has made it possible not only
to improve production yields considerably, but also to greatly facilitate
the labeling of proteins. So far, wheat germ- and E. coli-based cell-free
systems have been used to produce membrane proteins [72]. The
number of membrane proteins produced in cell-free systems that
have been used for NMR and X-ray studies is growing steadily (see
table 1 in [72]).
E. coli-based cell free systems can be based on extracts and puriﬁed
components [73,74]. Membrane proteins from both pro- and eukaryotic
origin have been produced in E. coli based cell-free systems [72]. They
have been produced as precipitates that were solubilized afterwards
using detergents. They also have been produced in a soluble form in the
presence of scaffolds like detergents, lipids, andnanolipoprotein particles.
Surprisingly, membrane proteins can assemble properly in the presence
of a scaffold in the absence of many of the factors that assist their biogen-
esis into the membrane in vivo. Compared to the in vivo situation, mem-
brane protein biogenesis in cell-free based system is a very slow process.
This may make it possible for membrane proteins to fold properly in a
more or less unassisted fashion. Notably, monitoring the production of
membrane proteins using cell-free based systems is greatly facilitated
by using membrane protein GFP-fusions (see e.g., [75] and Section 3).
For quite a number of membrane proteins produced in E. coli based
cell-free systems it has been shown that they are fully functional [74].
Recently, membrane protein complexes, including one containing co-
factors, have been produced using E. coli cell free systems (see e.g.,
[76,77]).
Taken together, E. coli-based cell free systems have become an im-
portant platform for the production of membrane proteins.
5. Bacteria other than E. coli as membrane protein production hosts
A priori there is no reasonwhy E. coli should bemore suitable for the
heterologous production of membrane proteins than any other bacteri-
um. In contrast, there may be good arguments why other bacteria could
be more suitable for the production of certain membrane proteins. E.g.,
bacteria with slower translation rates than E. coli may be able to deal
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have different (extended) repertoires of chaperones than E. coli, like
Gram-positive bacteria which express two copies of the integral mem-
brane chaperone YidC (e.g., Bacillus subtilis/L. lactis [78–81]), may per-
form better at insertion and assembly of heterologous membrane
proteins. Also, differences in the lipid composition of different bacterial
membranes may affect the insertion and assembly of heterologous
membrane proteins. Therefore, instead of optimizing E. coli for the
production of ‘difﬁcult’membraneproteins, a viable alternative strategy
is to look for different bacterial production hosts that have distinct
properties and may perform better for the protein of interest. The
Gram-positive bacteria L. lactis and B. subtilis have both been used for
the production of membrane proteins.
5.1. L. lactis as a membrane protein production host
One promising bacterial host for the production of membrane
proteins is L. lactis. It is a Gram-positive lactic acid bacterium, which is
used in the dairy industry. Because of the industrial interest in the
organism, its physiology has been studied in great detail. The organism
is genetically accessible and a variety of expression plasmids; both high
and low copy number plasmids and inducible promoters are available
[82]. The widely used nisin-A-based expression system has been used
for the production of membrane proteins in L. lactis [83,84]. There are
several notable cases in which functional production of eukaryotic as
well as bacterial membrane proteins (e.g., the human KDEL receptor
and the Na+/tyrosine transporter (Tyt1) of Fusobacterium nucleatum)
could be achieved in L. lactis, but not in E. coli [83–87]. Among the poten-
tial advantages of L. lactis are a slower growth rate than E. coli (~1 dou-
bling h−1 vs. ~1 doubling 0.5 h−1 for E. coli), which could be beneﬁcial
for the production of proteins that do not fold easily; the presence of a
single membrane only, which facilitates functional characterization; and
the lack of excessive proteolytic activity, which may help to prevent
breakdown of produced proteins. Just like in E. coli, co-production ofmul-
tiple proteins from different plasmids is possible in L. lactis and can be
used for chaperone production alongside themembrane protein of inter-
est [88]. Two recent studies have shown that L. lactis also can be
used for efﬁcient incorporation of amino acid derivatives in pro-
duced proteins [89,90]. This makes the organism a more complete
alternative to E. coli for production of proteins for X-ray crystallography,
where Seleno-methionine incorporation is routinely used for phase
determination.
Similar to E. coli, the consequences of membrane protein production
in L. lactis have been studied and used as a starting point for strain en-
gineering [91–93].Membrane protein production in L. lactis leads to heat-
shock and cell envelope stress, and impairs growth. The cell envelope
stress response, controlled by the two-component regulatory CesSR
system, seems to play a key role in the adaption of L. lactis to the toxic
effects of membrane protein production. In keeping with these observa-
tions, the capability of L. lactis to produce a membrane protein was se-
verely hampered when the genes encoding the CesSR system itself or
genes encoding particular members of the CesSR regulon were knocked
out [93]. On the other hand, overexpressing cesSR reduced the growth
defect, thereby improving membrane protein production yields [93].
Interestingly, genes encoding homologs of E. coli FtsH (involved in quality
control and degradation of membrane proteins) and YidC (involved in
the insertion and folding of membrane proteins) are part of the CesSR
regulon. In contrast to E. coli, there are no indications that in L. lactis – at
least under the conditions used – the Sec-translocon capacity is
the main bottleneck hampering the production of membrane proteins.
Thus, the bottlenecks hampering the production of membrane proteins
in E. coli and L. lactis seem to be – at least partially – different.
Finally, L. lactis strains with improved membrane protein production
characteristics have been isolated using a screening approach [41]. By
fusing GFP and an erythromycin resistance marker in tandem to the C-
terminus of a target protein, it is possible to simultaneously select forstrains with enhanced membrane protein production characteristics
(increased erythromycin resistance) and insertion in the membrane
(GFP ﬂuorescence) (see Section 3). All characterized L. lactis strains that
were isolated in this screen carried single-site mutations in the nisK
gene. NisK is the sensor protein of a two-component regulatory system
that directs nisin-A-mediated expression of the genes encoding the target
proteins. The mutations seem to lead to higher expression levels of the
genes encoding the membrane proteins of interest, thereby improving
production yields. All this is in keeping with the Sec-translocon capacity
not being a factor limiting the production of membrane proteins in
L. lactis under the condition used.
5.2. B. subtilis as a membrane protein production host
TheGram-positive bacterium B. subtilis is widely used in industry for
the production of secretory proteins [79]. The physiology of B. subtilis
has been studied in great detail, it is genetically very well accessible
and a variety of expression systems is available. Recently, B. subtilis
was also used to produce membrane proteins [94]. It was found that
membrane-associated stress-responsive systems set major limits to
the production of membrane proteins in B. subtilis. It was shown that
the removal of these systems can signiﬁcantly improve the membrane
protein production yields. However, it is not known if these im-
proved yields also represent properly folded material. The removal
of membrane-associated stress-responsive systems can negatively
affect the quality control of produced membrane proteins and as a
consequence the degradation of misfolded material.
Besides E. coli, L. lactis and B. subtilis other bacteria may also be good
production hosts for certainmembrane proteins. An important question
is: which organism to choose for the protein of interest? There is no
general answer to this question, because it is impossible to predict
how heterologously produced proteins will behave in different hosts.
However, when producing prokaryotic proteins it is likely best to
choose a host that is as closely related to the natural host of the protein
to be produced, so as to mimic homologous expression as closely as
possible. For example, when the E. coli and L. lactis were compared for
the production of membrane proteins from Salmonella Typhimurium,
E. coli – not surprisingly – performedmuch better than L. lactis, because
E. coli is a member of the closest known genus to Salmonella [95,96].
6. Engineering and isolating membrane protein variants with
improved production characteristics
Rather than engineering or changing the production host an alterna-
tive strategy to improvemembrane protein production yields in bacteria,
is to engineer the membrane protein of interest. It has been known for a
long time thatmodifyingN- and C-termini can improve production yields
signiﬁcantly. Recently, also mutagenesis approaches have been used to
isolate genes encoding membrane protein variants that are produced at
higher yields than the wild-type protein.
6.1. Modifying N- and C-termini
Many pro- and eukaryotic membrane proteins have N-terminal tails
that have to be translocated across themembrane [97–99]. Translocation
of an N-terminal tail depends on the ability of the N-terminus to remain
in a translocation competent conformation, the number of positively
charged residues in the tail region, and the ‘strength’ of the ﬁrst trans-
membrane segment, i.e., the charge difference, the length, and the overall
hydrophobicity of the reverse-signal anchor [85]. The inability to efﬁ-
ciently translocate theN-terminal tail of amembraneproteinmay severe-
ly hamper its production. Indeed, the functional production of the yeast
mitochondrial carrier AAC2 (ADP/ATP exchanger) can be increased in
L. lactis if the N-terminus is shortened, or the N-terminal tail is swapped
with a shorter one taken from the isoformAAC3 [85]. Likewise, functional
production of e.g., the rat neurotension receptor (NTR), a GPCR, could be
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secretory signal sequence to its N-terminus [100]. An SRP-dependent var-
iant ofM13pro-coat protein (P8CBD)has also beenused as anN-terminal
fusion partner that promotes the efﬁcient production of membrane pro-
teins in E. coli [61]. Practical features like a ﬂag-tag (for protein detection)
anda chitine bindingdomain (for protein puriﬁcation)were incorporated
into the P8CBD fusion partner. The N-terminal addition of Mistic, a small
protein that is unique to B. subtilis, has been reported to improve the
production of various pro- and eukaryotic membrane proteins in E. coli
and L. lactis [101–106]. The mechanism by which Mistic improves mem-
brane protein production yields is not clear.
The ability of various additions and combinations of C-terminal tags
(e.g., biotinylation-, poly histidine-, ﬂag- and strep-tags), or single
additions of either a polyhistidine/c-Myc epitope or E. coli thioredoxin
(aa 2–109) fusion, to improve the production of the aforementioned
MBP-NTR fusion was tested [100]. The most signiﬁcant improvement
of production was obtained with thioredoxin, which was attributed to
the remarkable stability of the globular protein. The combined use of
an N-terminal MBP and a His-tagged C-terminal thioredoxin fusion,
has also been successfully employed for the production of other GPCRs
in E. coli [107–109]. To remove N- and C-terminal fusion-partners from
target membrane proteins site-speciﬁc proteases can be used (see e.g.,
[43,44,61,109]).
Can fusion tags somehow affect the quality of produced membrane
protein material? It has been shown that in E. coli not properly folded
membrane proteins that are bona ﬁde FtsH substrates can be stabilized
when they are C-terminally fused to a properly folded periplasmic
PhoA moiety [110]. PhoA has two intramolecular disulﬁde bridges,
which are critical for its stability, and disulﬁde bond formation in the
periplasm is mediated by the disulﬁde bond formation (Dsb) system
[111]. However, in a strain background lacking the Dsb system PhoA
cannot fold properly and as a consequence the membrane protein
PhoA fusions are readily degraded by FtsH. Thus, properly folded PhoA
makes that the processive protease FtsH cannot pull themembrane pro-
tein PhoA fusions out of themembrane [22]. Therefore, when using sta-
ble fusion tags to enhance membrane protein production yields it
should be kept in mind that they may promote the accumulation of
not properly folded material.
6.2. Mutagenesis
Production levels ofmembrane proteins in bacteria can be improved
not only bymodifying N- and C-termini, but also by random and direct-
ed mutagenesis of the genes encoding membrane proteins can be used
as a starting point to isolate variants that have improved production
characteristics. Recently, random mutant libraries of genes encoding
for nine membrane proteins were screened for production in E. coli
using the CoFi blotting method [38] (see Section 3). For ﬁve out of the
nine proteins tested, one cycle of random mutagenesis of the genes
encoding these proteins resulted in signiﬁcant improvements of yields
of detergent solubilized membrane protein. Among the ﬁve proteins
was the human microsomal glutathione S-transferase 2. Notably, the
mutations that improved production of this variant of the protein did
not interfere with its activity. It should be noted that it is not known
how the various mutations contribute to the higher membrane protein
production yields.
A genemutant library approachwas alsoused to isolateNTR variants
from rat with improved production characteristics in E. coli [53]. The
gene encodingNTRwas randomlymutagenized and theNTRderivatives
were produced as an N-terminal MBP and C-terminal thioredoxin
fusions (see Section 6.1.). NTR accumulation levels were monitored di-
rectly using a ﬂuorescently labeled ligand that only properly folded pro-
tein can bind. Cells producing the largest number of functional receptors
exhibited the greatest ﬂuorescence and were isolated using FACS. This
way a GPCR variant, DO3, that shows much higher production yields
in E. coli but is still fully functional was isolated. The beauty of thisapproach is that the ﬂuorescently labeled ligand allows screening for
variants that not only are better produced, but also are still properly
folded in a single experiment. For DO3 it has been shown that the pro-
tein is also more stable when solubilized and puriﬁed than wild-type
NTR. Using E. coli as a production platform, ﬂuorescently labeled ligands
and extensive gene mutant libraries, the production yields and deter-
gent stability of DO3 and also other GPCRs have been further improved
[112–114].
Recently, it was shown that single E. coli cells of a library, each pro-
ducing a different GPCR variant, can be encapsulated to formdetergent-
resistant, semipermeable nano-containers or capsules, which can be
used for the identiﬁcation of well produced and detergent stable vari-
ants [115,116]. This method is called CHESS, which stands for cellular
high-throughput encapsulation, solubilization and screening (Fig. 3).
Importantly, in contrast to the E. coli cells the capsules used in the
CHESS method are not dissolved by detergents. This makes it possible
to solubilize the GPCRs in the capsules while maintaining an association
with the genetic information encoding the protein. The pore size of the
capsules can be controlled such thatﬂuorescently labeled ligands can go
in the container but the solubilized receptor cannot go out. Fluorescent-
ly labeled ligands are used to bind to those GPCR variants inside the
nano-containers that remain active in detergent. With the use of FACS
the capsules containing genes encoding well-produced and detergent-
stable GPCR variants can be isolated based on their ﬂuorescence.
Finally, using E. coli as a production platform GPCR variants with im-
proved thermostability has been isolated using Ala/Leu-scanning and
some of the created variants have been subsequently crystallized (see
e.g., [117–120]).
A prerequisite for using the above described mutagenesis approaches
is that a relatively easy folding/activity assay is available. It also should
be noted that even though the by mutagenesis created variants are
functional, there are concerns if these variants really represent the
wild-type protein.
7. Future perspectives
In recent years, considerable progress has been made with the
development of bacterial-based systems for the production of both
pro- and eukaryotic membrane proteins. However, there appears to
be ample room for improvements.
For soluble proteins it has been shown that chaperones with in-
creased folding efﬁciency towards speciﬁc target proteins can be created
[121]. Thus, it should also be possible to optimize bacterial components
involved in membrane protein biogenesis for the production of (het-
erologous) membrane proteins. Some membrane proteins require
membrane-protein-speciﬁc chaperones for their biogenesis. To im-
prove the heterologous production yields of these membrane proteins,
co-production of these speciﬁc chaperones may be used.
It has been shown that production yields of soluble eukaryotic pro-
teins can be enhanced considerably in an E. coli strain carrying muta-
tions in the ribosome that slow down the rate of translation [122]. It
would be interesting to study the effect of these ribosomal mutations
on (heterologous) membrane protein production yields. Using a very
limited test set it has been shown that lowering the growth rate and ac-
etate production of E. coli can enhance membrane protein production
yields [123]. It would be very interesting to extend this study by testing
the production of more (heterologous) membrane proteins and moni-
tor the functionality of the produced material.
The lipid composition of themembrane can be important for proper
folding, stability and function of produced membrane proteins (see e.g.,
[124]). Our rapidly growing knowledge of the biosynthesis of lipids/
membranes may make it possible to also engineer bacterial strains
with a lipid composition that is better suited for the production of spe-
ciﬁc membrane proteins and create more ‘membrane space’ to accom-
modate produced membrane proteins. Recently, in the yeast
Saccharomyces cerevisiae the composition of the membrane has been
Fig. 3. The CHESSmethod. A library of genes encoding receptormutants (a) is transformed and produced in the innermembrane of E. coli (b). Subsequently, cells are encapsulated (c) and
the cell envelope is permeabilized/solubilized with detergent (d), leading to a solubilization of the receptor. The encapsulation layer serves as a semipermeable barrier, retaining the sol-
ubilized receptor and its genetic informationwithin the capsule but allowingﬂuorescently labeled ligand into the capsule,where it can bind to functional receptors (e). Capsules containing
detergent-stable receptormutants aremore ﬂuorescent and can be sorted from the populationwith FACS (f). Geneticmaterial is recovered from the sorted capsules (g) and used to either
identify desired receptor mutants or serve as a template for further rounds of mutation or selection (h). Picture was taken from [115].
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The cholesterol biosynthetic pathway of mammalian cells was
reconstituted in this yeast enabling it to make cholesterol-like sterols,
which increases the capacity to make GPCRs in yeast.
Most eukaryotic membrane proteins are glycosylatedwhen inserted
into the endoplasmic reticulum (ER) membrane, and for a considerable
number of them this is essential for proper folding, stability and also
function [31]. The bacteria used thus far to produce membrane pro-
teins are not able to glycosylate them at all. However, efforts are
being made to engineer bacteria that can glycosylate proteins in a
way resembling the kinds of glycosylation that occur in eukaryotic
systems [126]. For the yeast Pichia pastoris it has been shown that
it is possible to engineer strains that can glycosylate proteins similar
to humans [127].
Cell-based membrane protein production is usually done in batch
cultures. Recently, a fed-batch (i.e., high cell density) cultivation set-
up was used for the efﬁcient E. coli-based production of a GPCR for
NMR experiments [128]. It has been shown that for L. lactis modifying
the composition of the culture medium such that key nutrients are not
limiting can also help to improve membrane protein production yields
signiﬁcantly [129]. Thus, taking amore ‘industrial’ approach to culturing
cells used for the production ofmembrane proteinsmay be a simple but
very effective manner to improve production yields.
E. coli cell-free based systems have been successfully used to pro-
duce membrane proteins. It has now been shown that these systems
can be scaled up and they are becoming less costly [130]. These develop-
ments will most likely help to further strengthen the position of these
systems for the production of membrane proteins.
Combining different technologies and methodologies can have
an additive effect on bacterial-basedmembrane protein production
yields as e.g., nicely shown by the CHESS method. Combining differ-
ent strain and protein engineering approaches is an obvious thing
to try next.
It is beyond any doubt that further developing bacterial-basedmem-
brane protein production platforms will greatly stimulate functional
and structural studies of this important class of proteins.
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